Skip to main contentSkip to navigation
Sirius Investors
Vericel Corporation

Vericel Corporation

VCEL
NASDAQHealthcare

Vericel Corporation (VCEL) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Vericel Corporation's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
109.12
Weak
WeakModerateStrong
P/B Ratio
5.14
Moderate
WeakModerateStrong
Earnings Yield
0.91%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
4.66%
Weak
WeakModerateStrong
Operating Margin
4.00%
Weak
WeakModerateStrong
Net Profit Margin
5.98%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
16.45%
Strong
WeakModerateStrong
Net Income Growth
59.41%
Strong
WeakModerateStrong
EPS Growth
57.14%
Strong
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
5.03
Strong
WeakModerateStrong
Quick Ratio
4.68
Strong
WeakModerateStrong
Asset Turnover
0.57x
Moderate
WeakModerateStrong
Inventory Turnover
4.02x
Moderate
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
1.36%
Weak
WeakModerateStrong
EV / Free Cash Flow
73.54x
Weak
WeakModerateStrong
Net Debt / EBITDA
-0.06x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.573
Strong
WeakModerateStrong
Return on Invested Capital
2.32%
Weak
WeakModerateStrong
Cash Conversion Cycle
120.77 days
Weak
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for VCEL.

View Financial Statements